Literature DB >> 7806638

Phosphorylation of caldesmon by smooth-muscle casein kinase II.

C Sutherland1, B S Renaux, D J McKay, M P Walsh.   

Abstract

A caldesmon kinase activity was partially purified from an extract of chicken gizzard smooth muscle by sequential chromatography on columns of DEAE-Sephacel, MonoQ and Superose 12. This kinase was identified as casein kinase II by Western blotting using peptide-directed antibodies raised against the alpha, alpha' and beta subunits of human casein kinase II; the smooth muscle enzyme consisted of similar subunits of M(r) 43,000 (alpha), 39,000 (alpha'), and 27,000 (beta). Phosphorylation of caldesmon and casein by smooth muscle casein kinase II was optimal at approximately 0.1 M NaCl, did not require second messengers, and was inhibited by heparin. The kinase utilized either GTP or ATP as a substrate. Caldesmon was phosphorylated to approximately 1 mol Pi mol-1 caldesmon by smooth muscle casein kinase II with a Km for caldesmon of 4.9 microM. Two-dimensional thin-layer electrophoresis indicated phosphate incorporation into both serine and threonine. All the incorporated phosphate was recovered in the N-terminal peptide (residues 1-152) generated by cleavage at cysteine 153 with 2-nitro-5-thiocyanobenzoic acid. Purification of tryptic phosphopeptides and N-terminal sequencing revealed two principal sites of phosphorylation: serine 73 and threonine 83. The following four synthetic peptides corresponding to this domain of caldesmon were examined as substrates of casein kinase II: A = RRREVNAQNSVAEEE; B = AQNSVAEEE; C = RSTDDEAA; D = SVAEEETKRSTDDE. Interestingly, only peptides C and D were phosphorylated and both only at threonine. Phosphorylation of intact caldesmon did not affect the pattern of chymotryptic digestion suggesting that it does not induce a significant conformational change in the protein substrate. Phosphorylation also had no effect on the binding of caldesmon to actin or on the caldesmon-mediated inhibition of actomyosin MgATPase activity. However, phosphorylation completely abolished the interaction of caldesmon with immobilized smooth muscle myosin. These results are consistent with the localization of the myosin-binding domain near the N-terminus of caldesmon and of the actin-binding domain near the opposite end of the elongated molecule. Casein kinase II may therefore play a role in regulating caldesmon-myosin interaction and the ability of caldesmon to cross-link actin and myosin filaments in smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806638     DOI: 10.1007/bf00122118

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  59 in total

1.  Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells.

Authors:  T J Childs; M H Watson; J S Sanghera; D L Campbell; S L Pelech; A S Mak
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

Review 2.  Casein kinase 2: an 'eminence grise' in cellular regulation?

Authors:  L A Pinna
Journal:  Biochim Biophys Acta       Date:  1990-09-24

Review 3.  Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.

Authors:  K Sobue; J R Sellers
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

4.  Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin.

Authors:  C Sutherland; M P Walsh
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

5.  Phosphorylation of smooth muscle caldesmon by calmodulin-dependent protein kinase II. Identification of the phosphorylation sites.

Authors:  M Ikebe; S Reardon
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Phosphorylation of caldesmon.

Authors:  J C Abougou; M Hagiwara; T Hachiya; M Terasawa; H Hidaka; D J Hartshorne
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

9.  Purification and characterization of an autophosphorylation-activated protein serine threonine kinase that phosphorylates and inactivates protein phosphatase 2A.

Authors:  H Guo; S A Reddy; Z Damuni
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

10.  Cloning and expression of a smooth muscle caldesmon.

Authors:  J Bryan; M Imai; R Lee; P Moore; R G Cook; W G Lin
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

View more
  5 in total

1.  The size and shape of caldesmon and its fragments in solution studied by dynamic light scattering and hydrodynamic model calculations.

Authors:  E A Czuryło; T Hellweg; W Eimer; R Dabrowska
Journal:  Biophys J       Date:  1997-02       Impact factor: 4.033

Review 2.  c-Jun, at the crossroad of the signaling network.

Authors:  Qinghang Meng; Ying Xia
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

Review 3.  Calmodulin and the regulation of smooth muscle contraction.

Authors:  M P Walsh
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

4.  Microarray analysis of genes involved with shell strength in layer shell gland at the early stage of active calcification.

Authors:  Zhangguo Liu; Qi Zheng; Xueyu Zhang; Lizhi Lu
Journal:  Asian-Australas J Anim Sci       Date:  2013-05       Impact factor: 2.509

5.  Microarray analysis of retinal gene expression in chicks during imposed myopic defocus.

Authors:  Ruth Schippert; Frank Schaeffel; Marita Pauline Feldkaemper
Journal:  Mol Vis       Date:  2008-08-31       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.